Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

  • Rohit Loomba
  • , Eric J. Lawitz
  • , Juan Pablo Frias
  • , Grisell Ortiz-Lasanta
  • , Lars Johansson
  • , Bridgette Boggess Franey
  • , Linda Morrow
  • , Moti Rosenstock
  • , Cynthia L. Hartsfield
  • , Chao Yin Chen
  • , Leo Tseng
  • , R. Will Charlton
  • , Hank Mansbach
  • , Maya Margalit

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Food Science